# OnCo record paper-rtog-9802-buckner-nejm-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rtog-9802-buckner-nejm-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rtog-9802-buckner-nejm-2016" ;
  schema:name "RTOG 9802: radiation plus procarbazine, lomustine and vincristine in high-risk low-grade glioma"@en ;
  schema:description "Adding PCV chemotherapy after radiotherapy for grade 2 glioma in adults who were over 40 or had residual tumour lengthened median survival from about eight to over thirteen years, one of the largest gains ever seen in neuro-oncology."@en ;
  schema:url <https://onco.cc/key-papers/paper-rtog-9802-buckner-nejm-2016/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1500925>, <https://pubmed.ncbi.nlm.nih.gov/27050206/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1500925> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Buckner JC, Shaw EG, Pugh SL, et al." ;
  onco:cancers <https://onco.cc/cancers/idh-mutant-astrocytoma/>, <https://onco.cc/cancers/oligodendroglioma/> ;
  onco:drugs <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/vincristine/> ;
  onco:journals <https://onco.cc/journals/nejm/> .